Paul Biondi is a Managing Partner at Flagship Pioneering, overseeing Pioneering Medicines and partnering efforts. He previously spent seventeen years at Bristol-Myers Squibb and holds an MBA from Northwestern University and a B.A. from Dartmouth College.
At firms with a similar stage, sector and check size.





One email when Paul's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckPaul Biondi is a Managing Partner at Flagship Pioneering, overseeing Pioneering Medicines and partnering efforts. He previously spent seventeen years at Bristol-Myers Squibb and holds an MBA from Northwestern University and a B.A. from Dartmouth College.
Flagship Pioneering has not reported a check size. It invests at pre-seed, seed.
A warm intro from a founder Flagship Pioneering backed works best.
Mercer Management Consulting; Senior Vice President of Strategy and Business Development at Bristol-Myers Squibb (BMS); Mercer Management Consulting.
Last updated 2026-10-15. Is this you? Ask for a correction.